

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.40973781 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.35408233 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.05026772 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.02420090 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.87484057 |
| 6 | vocalization behavior (GO:0071625) | 5.86046122 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.57900843 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.50460641 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.40264138 |
| 10 | glutamate secretion (GO:0014047) | 5.37626129 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.37282230 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19342404 |
| 13 | protein localization to synapse (GO:0035418) | 5.11073190 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.09353108 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.03072875 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.90523587 |
| 17 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.86817869 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.80307326 |
| 19 | exploration behavior (GO:0035640) | 4.80066462 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.75072566 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.67683287 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.67675724 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.62515126 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 4.59322238 |
| 25 | amino acid import (GO:0043090) | 4.54029088 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 4.52898695 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.51243135 |
| 28 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.41417081 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.40102388 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.36641516 |
| 31 | long-term memory (GO:0007616) | 4.33024289 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 4.26910355 |
| 33 | neurotransmitter secretion (GO:0007269) | 4.26568525 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 4.25577295 |
| 35 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.23581517 |
| 36 | positive regulation of membrane potential (GO:0045838) | 4.23129827 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.22634544 |
| 38 | regulation of synaptic plasticity (GO:0048167) | 4.14778518 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.13724877 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 4.09206922 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 3.98682468 |
| 42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.93335881 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.86909107 |
| 44 | potassium ion homeostasis (GO:0055075) | 3.85510485 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.82016639 |
| 46 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.79523700 |
| 47 | positive regulation of synapse maturation (GO:0090129) | 3.73985207 |
| 48 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.73444452 |
| 49 | proline transport (GO:0015824) | 3.69555291 |
| 50 | layer formation in cerebral cortex (GO:0021819) | 3.67252503 |
| 51 | central nervous system myelination (GO:0022010) | 3.65692369 |
| 52 | axon ensheathment in central nervous system (GO:0032291) | 3.65692369 |
| 53 | potassium ion import (GO:0010107) | 3.63524292 |
| 54 | dendritic spine organization (GO:0097061) | 3.62377589 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.62153664 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.59497012 |
| 57 | positive regulation of neurotransmitter transport (GO:0051590) | 3.58017129 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.56354633 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.53635319 |
| 60 | behavioral fear response (GO:0001662) | 3.51399584 |
| 61 | behavioral defense response (GO:0002209) | 3.51399584 |
| 62 | transmission of nerve impulse (GO:0019226) | 3.50247995 |
| 63 | regulation of dendritic spine development (GO:0060998) | 3.49749842 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.49590159 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47440492 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.45998932 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.45869522 |
| 68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.42918147 |
| 69 | neurotransmitter transport (GO:0006836) | 3.42120640 |
| 70 | neuromuscular process controlling balance (GO:0050885) | 3.41532916 |
| 71 | neuron recognition (GO:0008038) | 3.41354400 |
| 72 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.41176856 |
| 73 | positive regulation of dendritic spine development (GO:0060999) | 3.39673218 |
| 74 | membrane depolarization (GO:0051899) | 3.38373365 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.35959671 |
| 76 | learning (GO:0007612) | 3.35413330 |
| 77 | vesicle docking involved in exocytosis (GO:0006904) | 3.34743356 |
| 78 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.34303506 |
| 79 | acidic amino acid transport (GO:0015800) | 3.34282196 |
| 80 | chemosensory behavior (GO:0007635) | 3.34259146 |
| 81 | L-amino acid import (GO:0043092) | 3.33424228 |
| 82 | cellular sodium ion homeostasis (GO:0006883) | 3.31251460 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.30651516 |
| 84 | fear response (GO:0042596) | 3.29847992 |
| 85 | response to histamine (GO:0034776) | 3.28788355 |
| 86 | auditory behavior (GO:0031223) | 3.28666049 |
| 87 | serotonin metabolic process (GO:0042428) | 3.24865813 |
| 88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23867052 |
| 89 | regulation of synaptic transmission (GO:0050804) | 3.22725523 |
| 90 | innervation (GO:0060384) | 3.22280660 |
| 91 | regulation of exocytosis (GO:0017157) | 3.22113349 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.21793842 |
| 93 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21084730 |
| 94 | synaptic vesicle transport (GO:0048489) | 3.20514731 |
| 95 | establishment of synaptic vesicle localization (GO:0097480) | 3.20514731 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20292803 |
| 97 | presynaptic membrane assembly (GO:0097105) | 3.20057505 |
| 98 | response to auditory stimulus (GO:0010996) | 3.19798215 |
| 99 | neuromuscular process controlling posture (GO:0050884) | 3.19499832 |
| 100 | regulation of neurotransmitter levels (GO:0001505) | 3.18951626 |
| 101 | activation of protein kinase A activity (GO:0034199) | 3.18717535 |
| 102 | axonal fasciculation (GO:0007413) | 3.17232629 |
| 103 | * G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.16737623 |
| 104 | long term synaptic depression (GO:0060292) | 3.16318676 |
| 105 | regulation of female receptivity (GO:0045924) | 3.14014424 |
| 106 | neuronal ion channel clustering (GO:0045161) | 3.12097474 |
| 107 | phosphorelay signal transduction system (GO:0000160) | 3.10139157 |
| 108 | regulation of glutamate secretion (GO:0014048) | 3.08822186 |
| 109 | neurotransmitter uptake (GO:0001504) | 3.08791660 |
| 110 | vesicle docking (GO:0048278) | 3.08324221 |
| 111 | membrane depolarization during action potential (GO:0086010) | 3.07874833 |
| 112 | dicarboxylic acid transport (GO:0006835) | 3.07383784 |
| 113 | * synaptic transmission (GO:0007268) | 3.06815146 |
| 114 | sodium ion export (GO:0071436) | 3.06544974 |
| 115 | regulation of synapse maturation (GO:0090128) | 3.05678600 |
| 116 | positive regulation of dendrite development (GO:1900006) | 3.05059091 |
| 117 | signal release (GO:0023061) | 3.04169242 |
| 118 | acid secretion (GO:0046717) | 3.04067747 |
| 119 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03803223 |
| 120 | membrane hyperpolarization (GO:0060081) | 3.02332277 |
| 121 | visual learning (GO:0008542) | 3.01803859 |
| 122 | startle response (GO:0001964) | 3.00440595 |
| 123 | prepulse inhibition (GO:0060134) | 3.00380084 |
| 124 | response to amphetamine (GO:0001975) | 2.98035374 |
| 125 | detection of calcium ion (GO:0005513) | 2.96811077 |
| 126 | cell communication by electrical coupling (GO:0010644) | 2.96564459 |
| 127 | neuromuscular process (GO:0050905) | 2.96281832 |
| 128 | behavioral response to cocaine (GO:0048148) | 2.96051029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.38285375 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73267333 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.27143838 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.24162417 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17143467 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82976865 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82976865 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.82312810 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.80835690 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77936616 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.75830387 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74995098 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65270367 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58307054 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.55969182 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55690716 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53395089 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53219491 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39018618 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.29135796 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28843097 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28715133 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21958141 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18887067 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07079283 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92994394 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85449629 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.83273768 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76982098 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76349505 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73912508 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70699952 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67179997 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65590709 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65520579 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61620476 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53552676 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50391258 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48957836 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46237729 |
| 41 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.45865932 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42665610 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42573238 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40214235 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39608897 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38484905 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37496316 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35492164 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34391715 |
| 50 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.33041506 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32437761 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32345209 |
| 53 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32152952 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31049704 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30581338 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28180628 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25141087 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24276451 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23567303 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23335612 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23038973 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20091406 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20011159 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.17412693 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15012925 |
| 66 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14520100 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14043769 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12312932 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11603850 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11285934 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10943357 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09661954 |
| 73 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09476513 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09302727 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09116733 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09056979 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08017601 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07346336 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06400985 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05456278 |
| 81 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.04772840 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04558843 |
| 83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03374552 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03184855 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02547006 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02524005 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02239027 |
| 88 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01959700 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01923928 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01322502 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01199571 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00597062 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00152139 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99639630 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98289073 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97411066 |
| 97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97264891 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96804241 |
| 99 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96595198 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96285383 |
| 101 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95891224 |
| 102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95745367 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95286323 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94940010 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94895921 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94364057 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93472345 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93362067 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91855582 |
| 110 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91468760 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.91151566 |
| 112 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90613587 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90426165 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90290488 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90215965 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89946961 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89461998 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89418734 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89418734 |
| 120 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.88575693 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88232012 |
| 122 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.88006611 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87497914 |
| 124 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87317318 |
| 125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87265182 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87247041 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85504329 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85263712 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84506444 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82603929 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78507092 |
| 132 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.77853160 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 0.77282024 |
| 134 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77021333 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.73616362 |
| 136 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.73573061 |
| 137 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72853682 |
| 138 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.72274310 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68989934 |
| 140 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.68230781 |
| 141 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.67952418 |
| 142 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.67134302 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67056130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.81521045 |
| 2 | MP0003880_abnormal_central_pattern | 5.17977967 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.43729914 |
| 4 | MP0002822_catalepsy | 4.12007702 |
| 5 | MP0004270_analgesia | 3.81323588 |
| 6 | MP0009745_abnormal_behavioral_response | 3.79721907 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.70849018 |
| 8 | MP0002064_seizures | 3.30836173 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 3.00027286 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.92503986 |
| 11 | MP0009046_muscle_twitch | 2.76714180 |
| 12 | MP0001486_abnormal_startle_reflex | 2.74738796 |
| 13 | * MP0002272_abnormal_nervous_system | 2.55693869 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.50078020 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.46311050 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.45424174 |
| 17 | MP0002736_abnormal_nociception_after | 2.29903214 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.17623733 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.15086916 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.94369503 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.87049244 |
| 22 | MP0001970_abnormal_pain_threshold | 1.86542719 |
| 23 | MP0008569_lethality_at_weaning | 1.83247064 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.80873796 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.79173624 |
| 26 | MP0003879_abnormal_hair_cell | 1.75102989 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.74315784 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.72323960 |
| 29 | MP0004858_abnormal_nervous_system | 1.72091537 |
| 30 | MP0004924_abnormal_behavior | 1.64209988 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.64209988 |
| 32 | MP0003787_abnormal_imprinting | 1.61856160 |
| 33 | MP0000778_abnormal_nervous_system | 1.60276794 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.59037904 |
| 35 | MP0002184_abnormal_innervation | 1.58687979 |
| 36 | MP0003329_amyloid_beta_deposits | 1.57833778 |
| 37 | MP0003123_paternal_imprinting | 1.47825391 |
| 38 | MP0001529_abnormal_vocalization | 1.43831873 |
| 39 | MP0001188_hyperpigmentation | 1.41103765 |
| 40 | MP0003633_abnormal_nervous_system | 1.40458653 |
| 41 | MP0000955_abnormal_spinal_cord | 1.38665292 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.34525126 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.32839598 |
| 44 | MP0003075_altered_response_to | 1.32666555 |
| 45 | MP0001984_abnormal_olfaction | 1.32553813 |
| 46 | MP0004885_abnormal_endolymph | 1.26525661 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.25798142 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.24307186 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.21097342 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.17168915 |
| 51 | MP0003631_nervous_system_phenotype | 1.16031881 |
| 52 | * MP0001905_abnormal_dopamine_level | 1.13909549 |
| 53 | MP0008872_abnormal_physiological_respon | 1.08848822 |
| 54 | MP0001177_atelectasis | 1.03475195 |
| 55 | MP0008874_decreased_physiological_sensi | 1.02658310 |
| 56 | MP0005409_darkened_coat_color | 1.00609613 |
| 57 | MP0004142_abnormal_muscle_tone | 1.00492899 |
| 58 | * MP0002152_abnormal_brain_morphology | 1.00347675 |
| 59 | MP0001346_abnormal_lacrimal_gland | 0.99477355 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.98843904 |
| 61 | MP0005535_abnormal_body_temperature | 0.88761953 |
| 62 | MP0004510_myositis | 0.85272768 |
| 63 | MP0004085_abnormal_heartbeat | 0.82676784 |
| 64 | MP0001963_abnormal_hearing_physiology | 0.81785994 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.80811351 |
| 66 | MP0000751_myopathy | 0.80492434 |
| 67 | MP0002876_abnormal_thyroid_physiology | 0.80331298 |
| 68 | MP0003690_abnormal_glial_cell | 0.79211135 |
| 69 | MP0002229_neurodegeneration | 0.78665016 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.78415895 |
| 71 | MP0004147_increased_porphyrin_level | 0.72949226 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.72116360 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.71594036 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.71163477 |
| 75 | MP0004742_abnormal_vestibular_system | 0.70692248 |
| 76 | MP0005499_abnormal_olfactory_system | 0.70165448 |
| 77 | MP0005394_taste/olfaction_phenotype | 0.70165448 |
| 78 | MP0000920_abnormal_myelination | 0.70037857 |
| 79 | MP0002090_abnormal_vision | 0.69750263 |
| 80 | MP0004484_altered_response_of | 0.69549256 |
| 81 | MP0005171_absent_coat_pigmentation | 0.69396217 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.69119560 |
| 83 | MP0008877_abnormal_DNA_methylation | 0.68488227 |
| 84 | MP0003632_abnormal_nervous_system | 0.68459503 |
| 85 | MP0000604_amyloidosis | 0.67125628 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.67073916 |
| 87 | MP0005623_abnormal_meninges_morphology | 0.65833883 |
| 88 | MP0003122_maternal_imprinting | 0.64904063 |
| 89 | MP0004130_abnormal_muscle_cell | 0.63891281 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.63619611 |
| 91 | MP0006292_abnormal_olfactory_placode | 0.63590610 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.62801898 |
| 93 | MP0003634_abnormal_glial_cell | 0.61510791 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.61484901 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.61101190 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.60989775 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.58392087 |
| 98 | * MP0001664_abnormal_digestion | 0.56226530 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.53785727 |
| 100 | MP0005166_decreased_susceptibility_to | 0.53724959 |
| 101 | MP0003283_abnormal_digestive_organ | 0.52482633 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.51457355 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.50159970 |
| 104 | MP0000579_abnormal_nail_morphology | 0.48500039 |
| 105 | MP0010768_mortality/aging | 0.48243115 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.48065005 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.47797793 |
| 108 | MP0004043_abnormal_pH_regulation | 0.47451854 |
| 109 | MP0010769_abnormal_survival | 0.46546656 |
| 110 | MP0010770_preweaning_lethality | 0.46337678 |
| 111 | MP0002082_postnatal_lethality | 0.46337678 |
| 112 | MP0000026_abnormal_inner_ear | 0.46102636 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.45839173 |
| 114 | MP0002873_normal_phenotype | 0.45428925 |
| 115 | MP0003956_abnormal_body_size | 0.45279765 |
| 116 | MP0003045_fibrosis | 0.44657502 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.44643643 |
| 118 | MP0002169_no_abnormal_phenotype | 0.43979662 |
| 119 | MP0003938_abnormal_ear_development | 0.42672553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.35361403 |
| 2 | Myokymia (HP:0002411) | 8.42085710 |
| 3 | Focal seizures (HP:0007359) | 6.37050050 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.51475504 |
| 5 | Visual hallucinations (HP:0002367) | 5.24162736 |
| 6 | Febrile seizures (HP:0002373) | 5.17668981 |
| 7 | Atonic seizures (HP:0010819) | 4.92168602 |
| 8 | Absence seizures (HP:0002121) | 4.39207871 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.38994330 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.23390759 |
| 11 | Dialeptic seizures (HP:0011146) | 4.13575454 |
| 12 | Action tremor (HP:0002345) | 3.83275430 |
| 13 | Broad-based gait (HP:0002136) | 3.82157084 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.78332952 |
| 15 | Hyperventilation (HP:0002883) | 3.75326250 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.70329833 |
| 17 | Poor eye contact (HP:0000817) | 3.68496024 |
| 18 | Cerebral hypomyelination (HP:0006808) | 3.61528843 |
| 19 | Amblyopia (HP:0000646) | 3.53786445 |
| 20 | Dysmetria (HP:0001310) | 3.37589438 |
| 21 | Depression (HP:0000716) | 3.36824606 |
| 22 | Tetraplegia (HP:0002445) | 3.30025475 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.24349762 |
| 24 | Anxiety (HP:0000739) | 3.24273962 |
| 25 | Ankle clonus (HP:0011448) | 3.19883874 |
| 26 | Abnormal social behavior (HP:0012433) | 3.18568672 |
| 27 | Impaired social interactions (HP:0000735) | 3.18568672 |
| 28 | Neuronal loss in central nervous system (HP:0002529) | 3.15159881 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.12735851 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 3.09595483 |
| 31 | Postural instability (HP:0002172) | 3.07620938 |
| 32 | Torticollis (HP:0000473) | 2.98407056 |
| 33 | Akinesia (HP:0002304) | 2.95433447 |
| 34 | Annular pancreas (HP:0001734) | 2.94413317 |
| 35 | Focal dystonia (HP:0004373) | 2.93488431 |
| 36 | Stereotypic behavior (HP:0000733) | 2.92019056 |
| 37 | Clonus (HP:0002169) | 2.87782634 |
| 38 | Truncal ataxia (HP:0002078) | 2.86755237 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.84743318 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.84287789 |
| 41 | Papilledema (HP:0001085) | 2.82158580 |
| 42 | Impaired smooth pursuit (HP:0007772) | 2.79731404 |
| 43 | Apathy (HP:0000741) | 2.74702431 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.68086253 |
| 45 | Drooling (HP:0002307) | 2.67437034 |
| 46 | Excessive salivation (HP:0003781) | 2.67437034 |
| 47 | Impaired vibratory sensation (HP:0002495) | 2.67053646 |
| 48 | Mutism (HP:0002300) | 2.62693344 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.61611555 |
| 50 | Urinary urgency (HP:0000012) | 2.55891136 |
| 51 | Bradykinesia (HP:0002067) | 2.55760530 |
| 52 | Genetic anticipation (HP:0003743) | 2.55671617 |
| 53 | Absent speech (HP:0001344) | 2.52222801 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.50693616 |
| 55 | Scanning speech (HP:0002168) | 2.49686856 |
| 56 | Sleep apnea (HP:0010535) | 2.49063172 |
| 57 | Diplopia (HP:0000651) | 2.48635374 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.48635374 |
| 59 | Diminished motivation (HP:0000745) | 2.47762751 |
| 60 | Insomnia (HP:0100785) | 2.47267451 |
| 61 | Hemiparesis (HP:0001269) | 2.47165478 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.45377322 |
| 63 | Spastic tetraparesis (HP:0001285) | 2.42710350 |
| 64 | Progressive inability to walk (HP:0002505) | 2.40183667 |
| 65 | Rigidity (HP:0002063) | 2.37394737 |
| 66 | Intention tremor (HP:0002080) | 2.36290676 |
| 67 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.34676107 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.34461198 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34434418 |
| 70 | Incomplete penetrance (HP:0003829) | 2.33509309 |
| 71 | Megalencephaly (HP:0001355) | 2.30845329 |
| 72 | Spastic gait (HP:0002064) | 2.29651250 |
| 73 | Inability to walk (HP:0002540) | 2.29205696 |
| 74 | CNS hypomyelination (HP:0003429) | 2.28915237 |
| 75 | Hemiplegia (HP:0002301) | 2.28467201 |
| 76 | Abnormality of the corticospinal tract (HP:0002492) | 2.27612519 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.23830628 |
| 78 | Obstructive sleep apnea (HP:0002870) | 2.22653373 |
| 79 | Status epilepticus (HP:0002133) | 2.22351700 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.19881534 |
| 81 | Hypsarrhythmia (HP:0002521) | 2.19533010 |
| 82 | Blue irides (HP:0000635) | 2.17252746 |
| 83 | Dysmetric saccades (HP:0000641) | 2.16767152 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.16167821 |
| 85 | Pointed chin (HP:0000307) | 2.13620617 |
| 86 | Choreoathetosis (HP:0001266) | 2.11913179 |
| 87 | Rapidly progressive (HP:0003678) | 2.09151622 |
| 88 | Protruding tongue (HP:0010808) | 2.09137477 |
| 89 | Lower limb asymmetry (HP:0100559) | 2.01411367 |
| 90 | Abnormality of saccadic eye movements (HP:0000570) | 1.99346522 |
| 91 | Bundle branch block (HP:0011710) | 1.99303809 |
| 92 | Split foot (HP:0001839) | 1.98509653 |
| 93 | Gait ataxia (HP:0002066) | 1.97894707 |
| 94 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95574846 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 1.95574846 |
| 96 | Abnormal EKG (HP:0003115) | 1.95571703 |
| 97 | Lower limb muscle weakness (HP:0007340) | 1.94798606 |
| 98 | Delusions (HP:0000746) | 1.94414339 |
| 99 | Polyphagia (HP:0002591) | 1.93872837 |
| 100 | Abnormality of salivation (HP:0100755) | 1.92453206 |
| 101 | Lower limb amyotrophy (HP:0007210) | 1.90679595 |
| 102 | Ankyloglossia (HP:0010296) | 1.90129579 |
| 103 | Bronchomalacia (HP:0002780) | 1.88510764 |
| 104 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88079421 |
| 105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88079421 |
| 106 | Resting tremor (HP:0002322) | 1.87732342 |
| 107 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.85533341 |
| 108 | Memory impairment (HP:0002354) | 1.84178412 |
| 109 | Deeply set eye (HP:0000490) | 1.84073675 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.83976338 |
| 111 | Abnormality of the periventricular white matter (HP:0002518) | 1.81890491 |
| 112 | Dementia (HP:0000726) | 1.81508906 |
| 113 | Inappropriate behavior (HP:0000719) | 1.81116094 |
| 114 | Palpebral edema (HP:0100540) | 1.80877499 |
| 115 | Unsteady gait (HP:0002317) | 1.77742291 |
| 116 | Spinal canal stenosis (HP:0003416) | 1.76877536 |
| 117 | Increased circulating renin level (HP:0000848) | 1.74981255 |
| 118 | Generalized hypopigmentation of hair (HP:0011358) | 1.73531321 |
| 119 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.72279936 |
| 120 | Thickened helices (HP:0000391) | 1.71628308 |
| 121 | Retinal dysplasia (HP:0007973) | 1.70139401 |
| 122 | Autism (HP:0000717) | 1.69556848 |
| 123 | Termporal pattern (HP:0011008) | 1.68412080 |
| 124 | Insidious onset (HP:0003587) | 1.68412080 |
| 125 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68185455 |
| 126 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68185455 |
| 127 | Aplasia involving bones of the extremities (HP:0009825) | 1.68185455 |
| 128 | Limb dystonia (HP:0002451) | 1.67932914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.96558621 |
| 2 | NTRK3 | 4.97367170 |
| 3 | MAP3K9 | 3.48887446 |
| 4 | DAPK2 | 2.92285684 |
| 5 | MAP3K4 | 2.54612668 |
| 6 | MINK1 | 2.45403161 |
| 7 | RIPK4 | 2.44893687 |
| 8 | PRPF4B | 2.38931132 |
| 9 | MAP2K7 | 2.38700847 |
| 10 | PRKD3 | 2.32424293 |
| 11 | KSR2 | 2.30782331 |
| 12 | DAPK1 | 2.06557410 |
| 13 | PAK6 | 2.05363827 |
| 14 | MARK1 | 1.95289052 |
| 15 | CAMKK1 | 1.90484857 |
| 16 | KSR1 | 1.84144421 |
| 17 | CASK | 1.83531585 |
| 18 | MAP3K12 | 1.79501399 |
| 19 | NTRK2 | 1.76181066 |
| 20 | MAP3K13 | 1.72306677 |
| 21 | TNIK | 1.71031203 |
| 22 | ARAF | 1.67534295 |
| 23 | NTRK1 | 1.63413261 |
| 24 | PLK2 | 1.59131382 |
| 25 | MAP2K4 | 1.57465308 |
| 26 | CDK5 | 1.56529114 |
| 27 | FES | 1.43855216 |
| 28 | SIK2 | 1.37932529 |
| 29 | GRK5 | 1.31767099 |
| 30 | STK38 | 1.30805354 |
| 31 | PRKCG | 1.30241615 |
| 32 | CDK19 | 1.28466444 |
| 33 | BMPR2 | 1.23589627 |
| 34 | MAP3K2 | 1.23043248 |
| 35 | PTK2B | 1.20710893 |
| 36 | RAF1 | 1.14423990 |
| 37 | CAMK1 | 1.14090764 |
| 38 | RIPK1 | 1.12672237 |
| 39 | MAPK13 | 1.09856643 |
| 40 | CAMK2A | 1.03760410 |
| 41 | CAMK2B | 0.96631044 |
| 42 | PINK1 | 0.95958808 |
| 43 | CAMKK2 | 0.89969569 |
| 44 | SGK223 | 0.88570737 |
| 45 | SGK494 | 0.88570737 |
| 46 | TYRO3 | 0.87550315 |
| 47 | SGK2 | 0.87423549 |
| 48 | MAP3K11 | 0.85490516 |
| 49 | TAOK1 | 0.85429408 |
| 50 | MAPK12 | 0.83200508 |
| 51 | CDK18 | 0.82513238 |
| 52 | UHMK1 | 0.81315796 |
| 53 | PRKCH | 0.79808010 |
| 54 | PNCK | 0.79510060 |
| 55 | CDK15 | 0.78974216 |
| 56 | PDK1 | 0.76812290 |
| 57 | STK11 | 0.75930643 |
| 58 | NME1 | 0.74931075 |
| 59 | SGK1 | 0.74795792 |
| 60 | SGK3 | 0.73606967 |
| 61 | CDK14 | 0.73178464 |
| 62 | NEK6 | 0.72803206 |
| 63 | TNK2 | 0.72043325 |
| 64 | SIK3 | 0.70803496 |
| 65 | CDK11A | 0.68794099 |
| 66 | MARK2 | 0.65760298 |
| 67 | MAP3K1 | 0.64346616 |
| 68 | OXSR1 | 0.63903856 |
| 69 | DYRK1A | 0.63626972 |
| 70 | PDPK1 | 0.63179392 |
| 71 | CAMK1D | 0.63099054 |
| 72 | MAP3K7 | 0.59509041 |
| 73 | FGR | 0.58013295 |
| 74 | PKN1 | 0.56792127 |
| 75 | AKT3 | 0.55865165 |
| 76 | CAMK1G | 0.53836747 |
| 77 | RET | 0.52938064 |
| 78 | ALK | 0.51651985 |
| 79 | CAMK4 | 0.51340260 |
| 80 | PAK3 | 0.50764425 |
| 81 | LIMK1 | 0.50754017 |
| 82 | PRKCE | 0.50316645 |
| 83 | TAOK2 | 0.49640069 |
| 84 | BRAF | 0.48559677 |
| 85 | TESK1 | 0.48160400 |
| 86 | CCNB1 | 0.47295413 |
| 87 | IRAK2 | 0.47281280 |
| 88 | MAP2K1 | 0.47042063 |
| 89 | DAPK3 | 0.45682297 |
| 90 | RPS6KA3 | 0.45007788 |
| 91 | PRKCZ | 0.42959833 |
| 92 | LATS2 | 0.42258470 |
| 93 | FYN | 0.41655563 |
| 94 | CAMK2D | 0.41220140 |
| 95 | MAP2K6 | 0.40933467 |
| 96 | BRSK1 | 0.40239719 |
| 97 | DMPK | 0.38587667 |
| 98 | CAMK2G | 0.37757853 |
| 99 | PRKG2 | 0.36432606 |
| 100 | LMTK2 | 0.36186009 |
| 101 | MAPK10 | 0.35388613 |
| 102 | CSNK1G2 | 0.34413658 |
| 103 | PHKG2 | 0.32997154 |
| 104 | PHKG1 | 0.32997154 |
| 105 | FER | 0.32080004 |
| 106 | ROCK2 | 0.30617237 |
| 107 | MOS | 0.30596704 |
| 108 | PRKCA | 0.30568755 |
| 109 | PRKCB | 0.30205417 |
| 110 | ERBB2 | 0.29256809 |
| 111 | NEK1 | 0.28676261 |
| 112 | CDC42BPA | 0.27607392 |
| 113 | MAPK8 | 0.27518253 |
| 114 | MAP3K6 | 0.27064040 |
| 115 | ROCK1 | 0.23413585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87778699 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.13408101 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.04592429 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.96393571 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.92914775 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75988701 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.75813529 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.75222278 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.61663310 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60000692 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.35113461 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20679059 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06264233 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04491915 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96796811 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.96088914 |
| 17 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.94874017 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79024685 |
| 19 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.77591782 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.71414632 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.71321085 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.69601949 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68602090 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.67413211 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.66583336 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64369287 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.54355541 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43580600 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39469572 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34917968 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32052276 |
| 32 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31168544 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.25807558 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21648066 |
| 35 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13890980 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10005651 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07778988 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.07218770 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06924963 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06501938 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05121801 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.05027638 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01524958 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99009608 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98401677 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98300726 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94812301 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91057511 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89892929 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88802892 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86371231 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84534252 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80999831 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80437397 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79113552 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.78652078 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78275335 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77954120 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73882634 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72813231 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71401317 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70554311 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70489549 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68809590 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64893707 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64702899 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63818974 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62792053 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62267869 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60110016 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59250533 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54826625 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53684322 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52330696 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51492513 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50962192 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47596317 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46162802 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46112468 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.45159474 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45007215 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44506199 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43991599 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42624070 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.41191026 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40500374 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39133845 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39044968 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38793018 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.37967552 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37827071 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36223142 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35526991 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35304849 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.35234145 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34836569 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33583048 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31461756 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31324887 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.30898318 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.25916910 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25679574 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24852459 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24402856 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23573603 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23490687 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23396810 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22859002 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22811753 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22010864 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21625904 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21277173 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19751726 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16817427 |

